Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet plasma PTH variation study in stable secondary hyperparathyroidism
2010-021465-72Phase 4Active
- Sponsor
- Dra. Mª Dolores Arenas
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Dra. Mª Dolores Arenas. Primary endpoint: Time course of intact parathyroid hormone during first 24 hours after cinacalcet. Started Jul 2010; status: active.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on 2010-021465-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021465-72.